Clinical Trial Update: Neo-adjuvant Treatment in Non-Small Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating neo-adjuvant treatment in non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED